The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance

T. E. Conley, A. Duncan, A. Modasia, A. C. Ford, D. M. Pritchard, F. Hildebrand, F. J. Warren, R. Spiller, C. S. Probert

Open source

DOI
10.1111/apt.70677
Published
2026-04-17
Container
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/apt.70677,
  title = {The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance},
  author = {T. E. Conley and A. Duncan and A. Modasia and A. C. Ford and D. M. Pritchard and F. Hildebrand and F. J. Warren and R. Spiller and C. S. Probert},
  year = {2026},
  journal = {Alimentary Pharmacology \& Therapeutics},
  doi = {10.1111/apt.70677},
  url = {https://doi.org/10.1111/apt.70677}
}

RIS

TY  - JOUR
TI  - The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance
AU  - T. E. Conley
AU  - A. Duncan
AU  - A. Modasia
AU  - A. C. Ford
AU  - D. M. Pritchard
AU  - F. Hildebrand
AU  - F. J. Warren
AU  - R. Spiller
AU  - C. S. Probert
PY  - 2026
JO  - Alimentary Pharmacology & Therapeutics
DO  - 10.1111/apt.70677
UR  - https://doi.org/10.1111/apt.70677
ER  - 

APA

Conley, T. E., Duncan, A., Modasia, A., Ford, A. C., Pritchard, D. M., Hildebrand, F., Warren, F. J., Spiller, R., & Probert, C. S. (2026). The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70677

Source records